108 Folgen

  1. BOLD fMRI in IDH mutant gliomas

    Vom: 10.12.2021
  2. Glioblastoma subtypes and response to Dasatinib

    Vom: 26.11.2021
  3. Resection for recurrent brain metastases

    Vom: 12.11.2021
  4. Incidental Meningiomas

    Vom: 29.10.2021
  5. Immunosuppression in IDH mutant gliomas

    Vom: 15.10.2021
  6. Immunotherapy for melanoma brain metastases

    Vom: 1.10.2021
  7. DNA methylation profiles within the CATNON trial

    Vom: 17.9.2021
  8. 18F FET PET in childhood CNS tumors

    Vom: 3.9.2021
  9. Checkpoint blockade in atypical meningiomas

    Vom: 20.8.2021
  10. Molecular signatures of glioma causation

    Vom: 6.8.2021
  11. Testing methods for MGMT promoter methylation

    Vom: 23.7.2021
  12. Temozolomide-induced hypermutation in IDH-mutant low-grade gliomas

    Vom: 9.7.2021
  13. Posterior fossa syndrome

    Vom: 18.6.2021
  14. Loss of H3K27me3 in meningiomas

    Vom: 4.6.2021
  15. Loss of H3K27me3 in the Tübingen meningioma cohort

    Vom: 21.5.2021
  16. A prospective phase II randomized trial of proton radiotherapy vs intensity modulated radiotherapy for patients with newly diagnosed GBM

    Vom: 7.5.2021
  17. Brain radiotherapy and decline in fine motor skills

    Vom: 9.4.2021
  18. A serum based DNA methylation assay to detect gliomas

    Vom: 26.3.2021
  19. PTEN deficiency and proteosome addiction in glioblastoma

    Vom: 12.3.2021
  20. Cold-Inducible RNA-Binding Protein expression and recurrence of brain metastases

    Vom: 26.2.2021

5 / 6

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site